The challenges of choosing the right target antigen in AML compared to ALL

Treatment outcomes for acute myeloid leukemia (AML) patients treated with immunotherapy have significantly lagged behind those achieved for acute lymphoblastic leukemia (ALL), and this is due to the f... Author: VJHemOnc Added: 05/29/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts